Cargando…

Public health impact and cost-effectiveness of the RTS,S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models

BACKGROUND: The phase 3 trial of the RTS,S/AS01 malaria vaccine candidate showed modest efficacy of the vaccine against Plasmodium falciparum malaria, but was not powered to assess mortality endpoints. Impact projections and cost-effectiveness estimates for longer timeframes than the trial follow-up...

Descripción completa

Detalles Bibliográficos
Autores principales:	Penny, Melissa A, Verity, Robert, Bever, Caitlin A, Sauboin, Christophe, Galactionova, Katya, Flasche, Stefan, White, Michael T, Wenger, Edward A, Van de Velde, Nicolas, Pemberton-Ross, Peter, Griffin, Jamie T, Smith, Thomas A, Eckhoff, Philip A, Muhib, Farzana, Jit, Mark, Ghani, Azra C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4723722/ https://www.ncbi.nlm.nih.gov/pubmed/26549466 http://dx.doi.org/10.1016/S0140-6736(15)00725-4

Ejemplares similares

Insights from modelling malaria vaccines for policy decisions: the focus on RTS,S
por: Galactionova, Katya, et al.
Publicado: (2021)

Drivers of differences in expected public health impact of RTS,S in individual countries of Africa: an individual-based modeling study
por: Penny, Melissa, et al.
Publicado: (2014)

Fun with maths: exploring implications of mathematical models for malaria eradication
por: Eckhoff, Philip A, et al.
Publicado: (2014)

Incidence and admission rates for severe malaria and their impact on mortality in Africa
por: Camponovo, Flavia, et al.
Publicado: (2017)

The public health impact of malaria vaccine RTS,S in malaria endemic Africa: country-specific predictions using 18 month follow-up Phase III data and simulation models
por: Penny, Melissa A, et al.
Publicado: (2015)

Estimated impact of RTS,S/AS01 malaria vaccine allocation strategies in sub-Saharan Africa: A modelling study
por: Hogan, Alexandra B., et al.
Publicado: (2020)

The thermostability of the RTS,S/AS01 malaria vaccine can be increased by co-lyophilizing RTS,S and AS01
por: Fortpied, Juliette, et al.
Publicado: (2020)

Cost of introducing and delivering RTS,S/AS01 malaria vaccine within the malaria vaccine implementation program
por: Baral, Ranju, et al.
Publicado: (2023)

Modelling the roles of antibody titre and avidity in protection from Plasmodium falciparum malaria infection following RTS,S/AS01 vaccination
por: Thompson, Hayley A., et al.
Publicado: (2020)

Costing RTS,S introduction in Burkina Faso, Ghana, Kenya, Senegal, Tanzania, and Uganda: A generalizable approach drawing on publicly available data
por: Galactionova, Katya, et al.
Publicado: (2015)

Cost-effectiveness and public health impact of RTS,S/AS01 (E) malaria vaccine in Malawi, using a Markov static model
por: Ndeketa, Latif, et al.
Publicado: (2021)

The time-course of protection of the RTS,S vaccine against malaria infections and clinical disease
por: Penny, Melissa A., et al.
Publicado: (2015)

Mosquirix™ RTS, S/AS01 Vaccine Development, Immunogenicity, and Efficacy
por: Nadeem, Aroosa Younis, et al.
Publicado: (2022)

Age-shifting in malaria incidence upon cessation of interventions: a simulation study
por: Pemberton-Ross, Peter, et al.
Publicado: (2014)

Economic Impact of Introducing the RTS,S Malaria Vaccine: Cost-Effectiveness and Budget Impact Analysis in 41 Countries
por: Sauboin, Christophe, et al.
Publicado: (2019)

Evaluation of RTS,S/AS02A and RTS,S/AS01B in Adults in a High Malaria Transmission Area
por: Polhemus, Mark E., et al.
Publicado: (2009)

Environmental modifiers of RTS,S/AS01 malaria vaccine efficacy in Lilongwe, Malawi
por: Bell, Griffin J., et al.
Publicado: (2020)

Potential public health impact of RTS,S malaria candidate vaccine in sub-Saharan Africa: a modelling study
por: Sauboin, Christophe J., et al.
Publicado: (2015)

Modelling the cost-effectiveness of introducing the RTS,S malaria vaccine relative to scaling up other malaria interventions in sub-Saharan Africa
por: Winskill, Peter, et al.
Publicado: (2017)

Impacts of Ecology, Parasite Antigenic Variation, and Human Genetics on RTS,S/AS01e Malaria Vaccine Efficacy
por: Bell, Griffin J., et al.
Publicado: (2021)

The Future of the RTS,S/AS01 Malaria Vaccine: An Alternative Development Plan
por: Gosling, Roly, et al.
Publicado: (2016)

Simulated Impact of RTS,S/AS01 Vaccination Programs in the Context of Changing Malaria Transmission
por: Brooks, Alan, et al.
Publicado: (2012)

A Phase IIa Controlled Human Malaria Infection and Immunogenicity Study of RTS,S/AS01(E) and RTS,S/AS01(B) Delayed Fractional Dose Regimens in Malaria-Naive Adults
por: Moon, James E, et al.
Publicado: (2020)

T Cell Responses to the RTS,S/AS01(E) and RTS,S/AS02(D) Malaria Candidate Vaccines Administered According to Different Schedules to Ghanaian Children
por: Ansong, Daniel, et al.
Publicado: (2011)

A mathematical model of the impact of present and future malaria vaccines
por: Wenger, Edward A, et al.
Publicado: (2013)

Implementation strategies for the introduction of the RTS,S/AS01 (RTS,S) malaria vaccine in countries with areas of highly seasonal transmission: workshop meeting report
por: Merle, Corinne S.
Publicado: (2023)

Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial
por: White, Michael T, et al.
Publicado: (2015)

Towards Eradication of Malaria: Is the WHO’s RTS,S/AS01 Vaccination Effective Enough?
por: Arora, Navneet, et al.
Publicado: (2021)

Should India be considering deployment of the first malaria vaccine RTS, S/AS01?
por: Rahi, Manju, et al.
Publicado: (2022)

RTS,S/AS01 Malaria Vaccine - The Next Step for a Developing Country
por: ZEHRA, ASMAT, et al.
Publicado: (2022)

RTS,S/AS01 malaria vaccine (Mosquirix(®)): a profile of its use
por: Syed, Yahiya Y.
Publicado: (2022)

Acceptance, availability, and feasibility of RTS, S/AS01 malaria vaccine: A review
por: Mumtaz, Hassan, et al.
Publicado: (2023)

The Relationship between RTS,S Vaccine-Induced Antibodies, CD4(+) T Cell Responses and Protection against Plasmodium falciparum Infection
por: White, Michael T., et al.
Publicado: (2013)

Impact of RTS,S/AS02(A) and RTS,S/AS01(B) on Genotypes of P. falciparum in Adults Participating in a Malaria Vaccine Clinical Trial
por: Waitumbi, John N., et al.
Publicado: (2009)

Optimal Population-Level Infection Detection Strategies for Malaria Control and Elimination in a Spatial Model of Malaria Transmission
por: Gerardin, Jaline, et al.
Publicado: (2016)

Randomized Controlled Trial of RTS,S/AS02(D) and RTS,S/AS01(E) Malaria Candidate Vaccines Given According to Different Schedules in Ghanaian Children
por: Owusu-Agyei, Seth, et al.
Publicado: (2009)

The biological function of antibodies induced by the RTS,S/AS01 malaria vaccine candidate is determined by their fine specificity
por: Chaudhury, Sidhartha, et al.
Publicado: (2016)

Induction of Plasmodium falciparum-Specific CD4(+) T Cells and Memory B Cells in Gabonese Children Vaccinated with RTS,S/AS01(E) and RTS,S/AS02(D)
por: Agnandji, Selidji T., et al.
Publicado: (2011)

Correction: Randomized Controlled Trial of RTS,S/AS02(D) and RTS,S/AS01(E) Malaria Candidate Vaccines Given According to Different Schedules in Ghanaian Children
por: Owusu-Agyei, Seth, et al.
Publicado: (2010)

State of inequality in malaria intervention coverage in sub-Saharan African countries
por: Galactionova, Katya, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_iigtsv6mcksn5tb5l946455n60